EASTMAN CHEMICAL CO
For the period ended Dec 31, 2024. Filed Feb 14, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 14, 2025
EMN$65.45+0.1%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 8. Consolidated Statements of Cash Flows
CONSOLIDATED STATEMENTS OF CASH FLOWS
| For years ended December 31, | |||
|---|---|---|---|
| (Dollars in millions) | 2024 | 2023 | 2022 |
| Operating activities | |||
| Net earnings | $908 | $896 | $796 |
| Adjustments to reconcile net earnings to net cash provided by operating activities: | |||
| Depreciation and amortization | 509 | 498 | 477 |
| Mark-to-market pension and other postretirement benefit plans (gain) loss, net | (54) | 53 | 19 |
| Asset impairment charges | 5 | — | — |
| (Gain) loss on sale of assets | — | (15) | 15 |
| (Gain) loss on divested businesses | — | (323) | 43 |
| Benefit from deferred income taxes | (52) | (102) | (136) |
| Changes in operating assets and liabilities, net of effect of acquisitions and divestitures: | |||
| (Increase) decrease in trade receivables | 28 | 126 | 93 |
| (Increase) decrease in inventories | (344) | 201 | (430) |
| Increase (decrease) in trade payables | 188 | (190) | 60 |
| Pension and other postretirement contributions (in excess of) less than expenses | (51) | (66) | (149) |
| Variable compensation payments (in excess of) less than expenses | 99 | 142 | (103) |
| Other items, net | 51 | 154 | 290 |
| Net cash provided by operating activities | 1,287 | 1,374 | 975 |
| Investing activities | |||
| Additions to properties and equipment | (599) | (828) | (611) |
| Government incentives | 9 | — | — |
| Proceeds from sale of businesses | 38 | 456 | 998 |
| Acquisitions, net of cash acquired | — | (77) | (1) |
| Other items, net | 18 | 17 | 6 |
| Net cash (used in) provided by investing activities | (534) | (432) | 392 |
| Financing activities | |||
| Net increase (decrease) in commercial paper and other borrowings | — | (326) | 326 |
| Proceeds from borrowings | 1,237 | 796 | 500 |
| Repayment of borrowings | (1,039) | (808) | (750) |
| Dividends paid to stockholders | (379) | (376) | (381) |
| Treasury stock purchases | (300) | (150) | (1,002) |
| Other items, net | 27 | (24) | (14) |
| Net cash used in financing activities | (454) | (888) | (1,321) |
| Effect of exchange rate changes on cash and cash equivalents | (10) | 1 | (12) |
| Net change in cash and cash equivalents | 289 | 55 | 34 |
| Cash and cash equivalents at beginning of period | 548 | 493 | 459 |
| Cash and cash equivalents at end of period | $837 | $548 | $493 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.